Michael Severino, EVP, R&D and CSO at AbbVie Inc. (ABBV), sold 32,969 shares at $117.93 ($3.9M) on 2018-02-28, disclosed to the SEC on 2018-03-02.
Open-market sale of $3.9M ABBV by EVP, R&D and CSO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $117.93 | 2,643 | $312K | 8.0% |
| 2 | $117.93 | 2,643 | $312K | 8.0% |
| 3 | $118.26 | 27,683 | $3.3M | 84.0% |
| Total | $118.21 avg | 32,969 | $3.9M | 100% |
| Filing → |
| ABBV | SELL | 2022-05-10 | $90.7M | — | Filing → |
| ABBV | SELL | 2020-11-06 | $17.0M | — | Filing → |
| ABBV | SELL | 2018-08-21 | $4.9M | — | Filing → |